Skip to main content

Advertisement

SpringerLink
Log in

Is increased serum S-100 protein concentration a marker of metastasis in malignant melanoma? A four-year experience report

  • EURAPS paper
  • Published:
European Journal of Plastic Surgery Aims and scope Submit manuscript

Abstract

Between October 1999 and October 2003, S-100 serum protein concentration was measured in 880 samples obtained from 178 consecutive patients with histologically-confirmed malignant melanoma. S-100 concentration was measured with an assay based on three monoclonal antibodies against bovine S-100 protein B-subunit, using an automated chemiluminescence analyzer (Liaison, Diasorin, Saluggia, Italy). This method is much faster (less than 1 h) than the available technology which has been employed in most of previous studies in this field, and allows the surgeon to integrate S-100 concentration levels in his decision-making about patient management and follow-up scheduling. Seventeen out of 178 patients (9.55%) had local or distant metastasis. In 14 of them (82.35%), S-100 levels were higher then 250 ng/L (decision level) when disease progression was detected. Furthermore, the follow-up for five patients showed that a renewed rise of S-100 concentration reflected a new tumor recurrence. Our results confirm that serum S-100 concentration rises with disease progression, and that increased levels are often the first symptoms of recurrence. Furthermore, the study adds to this notion the clinical gain provided by availability of S-100 values before patient evaluation. The management of patients is greatly improved, with benefit to both patient and surgeon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Abraha HD, Fuller LC, Du Vivier AWP, Higgins EM, Sherwood RA (1997) Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. J Dermatol 137:381

    CAS  Google Scholar 

  2. Aapro MS (1993) Advances in systemic treatment of melanoma. Eur J Cancer 29A: 613

    Article  Google Scholar 

  3. Bonfrer JMG, Korse CM, Nieweg OE, Rankin EM (1998) The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma. Br J Cancer 77(12): 2210

    CAS  PubMed  Google Scholar 

  4. Buer J, Probst M, Franzke A, Duensing S, Haindl J, Volkenandt M, Wittke F, Hoffmann R, Ganser A, Atzpodien J (1997) Elevated serum level of S-100 and survival in metastatic malignant melanoma. Br J Cancer 75(9):1373

    CAS  PubMed  Google Scholar 

  5. Cho KH, Hashimoto, Taniguchi Y (1990) Immunohistochemical study of melanocytic naevus and malignant melanoma with monoclonal antibodies against S-100 subunits. Cancer 66:765

    CAS  PubMed  Google Scholar 

  6. Cochran AJ (1988) Melanoma markers: biologic and diagnostic considerations. Monogr Pathol 30:35

    PubMed  Google Scholar 

  7. Cochran ALJ, Wen DR, Herschman HR (1982) Detection of S-100 protein as an aid to identification of melanocytic tumours. Int J Cancer 30:295

    CAS  PubMed  Google Scholar 

  8. Dannies PS, Levine L (1969) Demonstration of subunits in beef brain acidic protein S-100. Biochem Biophys Res Commun 37:587

    Article  CAS  PubMed  Google Scholar 

  9. Dorizzi RM, Cocco C, Bortolani A (2001) Reference interval of S-100 protein measurement using Liaision analyzer and comparison with the results yielded by Lia-mat analyzer. Melanoma Res 11(1):S80

    Google Scholar 

  10. Gaynor R, Herschman HR, Irie R, Jones P, Morton D, Cochran A (1981) S-100 protein: a marker for human malignant melanomas? Lancet 1:869

    Article  CAS  PubMed  Google Scholar 

  11. Gaynor R, Irie R, Morton D, Herschman HR (1980) S-100 protein is present in cultured human malignant melanomas. Nature 286:400

    Article  CAS  PubMed  Google Scholar 

  12. Guo HB, Stoffel-Wagner B, Bierwirth T, Mezger J, Klingmuller D (1995) Clinical significance of S-100 in metastatic malignant melanoma. Eur J Cancer 6:924

    Article  Google Scholar 

  13. Hansson LO, Von Shoultz E, Djureen E, Hansson J, Nilsson B, Ringborg U (1997) Prognostic value of serum S-100 protein B in malignant melanoma. Antican Res 17:3071

    CAS  Google Scholar 

  14. Haushild A, Michaelsen J, Brenner W, Rudolph P, Glaser R, Henze E, Cristophers E (1999) Prognostic significance of serum S-100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Res 9:155

    PubMed  Google Scholar 

  15. Hauschild A, Engel G, Brenner W, Glaser R, Monig H, Henze E, Christophers E (1999) S-100 protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology 56:338

    Article  CAS  PubMed  Google Scholar 

  16. Henze G, Dummer R, Joller-Jemelka HI, Boni R, Burg G (1997) Serum S-100. A marker for disease monitoring in metastatic melanoma. Dermatol 194:208

    CAS  Google Scholar 

  17. Isobe T, Ishioka N, Okuyama T (1981) Structural relation of two S-100 proteins in bovine brain; subunit composition of S-100 protein. Eur J Biochem 115:469

    CAS  PubMed  Google Scholar 

  18. Joseph E, Lyman G, Messina J, Brobeil A, Reintgen DS (1997) Tumor markers in malignant melanoma: a review. Tumor Marker Update 9:157

    Google Scholar 

  19. Jury CS, McAllister EJ, MacKie RM (2000) Rising levels of serum S-100 protein precede other evidence of disease progression in patients with malignant melanoma. Br J Dermatology 143:269

    Article  CAS  Google Scholar 

  20. Koh HK (1991) Cutaneous melanoma. N Engl J Med 325:171

    CAS  PubMed  Google Scholar 

  21. Karnell R, Von Schoultz E, Hansson LO, Nilsson B, Arstrand K, Kagedal B (1997) S-100 protein, 5-S-cysteinnyldopa and 6-hydroxy-5methoxyindole-2carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma. Melanoma Res 7:393

    CAS  PubMed  Google Scholar 

  22. Legha SS (1989) Current therapy for malignant melanoma. Sem Oncol 16:34

    CAS  Google Scholar 

  23. Miliotes G, Lyman GH, Cruse W, Puleo C, Albertini J, Rapaport D, Glass F, Fenske N, Soriano T, Cuny C, VanVoorhis N, Reintgen D (1996) Evaluation of new putative tumor markers for melanoma. Ann Surg Oncol 3(6):358

    PubMed  Google Scholar 

  24. Missler U, Wiessmann M (1995) Measurement of S-100 protein in human blood and cerebrospinal fluid: analytical method and preliminary clinical results. Eur J Clin Chem Clin Biochem 33:743

    CAS  PubMed  Google Scholar 

  25. Moore BW (1965) A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19:739

    Article  CAS  PubMed  Google Scholar 

  26. Moretti S, Spallanzani A, Pinzi C, Giannotti B (1997) Dal laboratorio al paziente. Quale utilità pratica della ricerca biologica nel melanoma?. G Ital Dermatol Venereol 132:407

    Google Scholar 

  27. Nakajima T, Watanabe S, Sato Y, Kameya T, Shimosato Y, Ishihara K (1982) Immunohistochemical demonstration of S-100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 50:912

    CAS  PubMed  Google Scholar 

  28. Ordonez NG, Ji XL, Hickey RC (1988) Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 90:385

    CAS  PubMed  Google Scholar 

  29. Waterloo K, Ingebrigtsen T, Romner B (1997) Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochir 139:26–32

    CAS  Google Scholar 

  30. Ingebrigsten T, Romner B, Kongstad P, Langbakk B (1995) Increase serum concentration of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psych 59:103–104

    CAS  Google Scholar 

  31. Dorizzi RM, Bortolani A, Caputo M (1999) Measurement of S-100 protein using the automated chemiluminescent system Lia-mat 300. Ann Clin Biochem 36:777–778

    CAS  PubMed  Google Scholar 

  32. http://www.poems.msu.edu/infomastery/Diagnosis/Diagnosis.htm (last access May 20, 2004)

  33. Schultz ES, Diepgen TL, Von Driesh P (1998) Clinical and prognostic relevance of serum S-100B protein in malignant melanoma. Br J Dermatol 138:426

    Article  CAS  PubMed  Google Scholar 

  34. Shutter EM, Visser JJ, Van Kamp GJ (1992) The utility of lipid-associated acids (LASA or LSA) as a serum marker for malignancy. A review of the literature. Tumour Biol 13:121

    PubMed  Google Scholar 

  35. Stefannsson K, Wollmamm RL, Moore BW (1982) Distribution of S-100 protein outside the central nervous system. Brain Res 234:309

    Article  PubMed  Google Scholar 

  36. von Schoultz E, Hansson LO, Djureen E, Hansson J, Karnell R, Stigbrand T, Ringborg U (1996) Prognostic value of serum analyses of S-100 B protein in malignant melanoma. Melanoma Res 6:133

    PubMed  Google Scholar 

  37. Vuoristo MS, Kellocumpu-Lehtinen P, Laine S, Parvinen LM, Hahka-Kemppinen M, Korpela M, Kumpulainen E (2000) The value of serum S-100B and interleukins as markers in advanced melanoma. Melanoma Res 10:237

    CAS  PubMed  Google Scholar 

  38. Wang X, Heller R, Van Voorhis N, Cruise CW, Glass F, Fenske N (1994) Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220:768

    CAS  PubMed  Google Scholar 

  39. Wibe E, Hannisdal E, Paus E, Aamdal S (1992) Neuron specific enolase as a prognostic factor in metastatic malignant melanoma. Eur J Cancer 28A:1692

    Article  Google Scholar 

  40. Yamaguchi H (1980) Studies on the immunohistochemical localisation of S-100 and GFA proteins in the rat nervous system and in human brain tumours. Brain Nerve 32:1055

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Plastic Surgery and Burn Center, Verona Hospital, Verona, Italy

    M. Governa, S. Gatti, A. Tambuscio, J. Minic & D. Barisoni

  2. Clinical Chemistry and Hematology Laboratory, Verona Hospital, Verona, Italy

    R.M. Dorizzi

Authors
  1. M. Governa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R.M. Dorizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Gatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Tambuscio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Minic
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Barisoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Governa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Governa, M., Dorizzi, R., Gatti, S. et al. Is increased serum S-100 protein concentration a marker of metastasis in malignant melanoma? A four-year experience report. Eur J Plast Surg 28, 17–20 (2005). https://doi.org/10.1007/s00238-004-0696-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00238-004-0696-9

Keywords

Search

Navigation